We are glad to announce that Sentinel Diagnostics (Sentinel CH. SpA), focused for 40 years on the development and production of in vitro diagnostic kits for clinical chemistry, immunochemistry, fecal testing, and molecular diagnostics, extends its expertise and activities in the field of chromatographyand mass spectrometry through the acquisition of EUREKA s.r.l.- LAB DIVISION
“This acquisition supports our plan to become an important player in the IVD assays development and production. With the extended capabilities we’ll be able to provide clinical laboratory with a wider catalogue of assays, from high throughput core lab tests to the most advanced, specialistic second level assays”, says, dr. Marco Buonaguidi, Sentinel Diagnostics’ Head of Sales and Marketing
For further information about the acquisition, please contact us at firstname.lastname@example.org or Eureka Lab Division at email@example.com
About EUREKA s.r.l.- LAB DIVISION
EUREKA s.r.l.- LAB DIVISION is an Italian company based in Chiaravalle (AN) which has been operating in IVD chromatographic market for 25 years, developing, producing and commercializing the world’s largest range of ready-to-use diagnostic kits for HPLC, GC, GC-MS, LC-MS/MS applications in the fields of Special Clinical Chemistry, Therapeutic Drug Monitoring, Occupational Toxicology and Forensic Toxicology.
For further information, please visit Eureka Lab Division’s website: www.eurekakit.com.
About Sentinel CH. SpA
Sentinel Diagnostics (Sentinel CH. SpA) is an innovative company that, through the development of its products, contributes to the growth of scientific knowledge and the improvement of people’s health in the diagnostic field. For 40 years, Sentinel Diagnostics, an Italian company based in Milan, has been developing and producing in vitro diagnostic devices for the most advanced Clinical Chemistry, Immunochemistry and Molecular Diagnostics platforms.